Abstract

Residual DNA methylation in the gastric mucosa after Helicobacter pylori (H. pylori) eradication may have a role in gastric carcinogenesis. We examined the association between morphologic features and promoter methylation status of non‐neoplastic gastric mucosa especially after H. pylori eradication. A total of 140 gastric specimens from 99 participants who had at least 6 months of post‐eradication period were examined. The magnifying narrow‐band imaging (NBI) endoscopic feature of gastric mucosa was divided into two types: restored‐small, round pits, accompanied with honeycomb‐like subepithelial capillary networks; atrophic‐well‐demarcated oval or tubulovillous pits with clearly visible coiled or wavy vessels. Methylation status of five candidate genes (MYOD1, SLC16A12, IGF2, RORA, and PRDM5) were examined by bisulfite pyrosequencing. The atrophic type, informative endoscopic features of intestinal metaplasia, demonstrated higher methylation levels in all five genes compared to the restored type (all P < 0.0001). In the restored type, methylation levels were significantly lower among the samples with longer post‐eradication period (for all genes, P < 0.0001), which was not observed in atrophic type (for all genes, P > 0.1). Multivariate analysis demonstrated that atrophic type or presence of intestinal held an independent factor for hyper methylation (odds ratio: 24.69, 95% confidence interval: 6.95–87.76, P < 0.0001). The atrophic type by the magnifying NBI and presence of intestinal metaplasia are the morphologic characteristics of residual DNA methylation of after H. pylori eradication, regardless of the post‐eradication period and it might be considered as the epigenetic irreversible point with H. pylori eradication.

Highlights

  • Promoter CpG island methylation and subsequent transcriptional repression are important mechanisms in many types of cancers, while the aberrant methylation is observed in non-­neoplastic tissues with aging and chronic inflammation [1, 2]

  • We showed that the methylation status of gastric mucosa after H. pylori eradication is closely associated with its endoscopic and histologic features

  • DNA methylation after H. pylori eradication is thought to be associated with gastric cancer predisposition [15], but the morphologic features of this residual methylation have not been clearly described

Read more

Summary

Introduction

Promoter CpG island methylation and subsequent transcriptional repression are important mechanisms in many types of cancers, while the aberrant methylation is observed in non-­neoplastic tissues with aging and chronic inflammation [1, 2]. H. pylori-­infected gastric mucosa is characterized as chronic inflammation and atrophy [5], leading to epigenetic changes characterized by the promoter methylation of multiple genes [6, 7]. This phenomenon can be explained by the concept of an “epigenetic-­field-­defect” which is linked to gastric cancer predisposition. Several studies have reported that H. pylori eradication prevents gastric cancer [8, 9], which might be attributed to the improvement of chronic inflammation or atrophy [10]. Various genotoxic and epigenetic changes in gastric mucosa which reflect past exposure of H. pylori infection might associate with the risk of gastric cancer after eradication. We investigated the association among methylation status, magnifying NBI and histologic features

Materials and Methods
Endoscopic procedure and sample collection
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call